2002
DOI: 10.1016/s1047-2797(01)00310-6
|View full text |Cite
|
Sign up to set email alerts
|

A Review of Genetic Polymorphisms and Prostate Cancer Risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
62
0
4

Year Published

2002
2002
2012
2012

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 99 publications
(71 citation statements)
references
References 53 publications
5
62
0
4
Order By: Relevance
“…Some of these prognostic markers also may be useful for disease diagnosis. [107][108][109][110][111][112][113][114] Although several series have failed to demonstrate any independent contribution of family history to the overall prognosis from prostate carcinoma, [115][116][117] it is well recognized that individuals with a family history of prostate carcinoma are at a higher risk for developing the disease than the general population. 107,118,119 The challenge for clinical research is the incorporation of appropriate risk markers into the most reliable and cost-effective models of disease outcome.…”
Section: Merging Prognosis and Diagnosis: Through A Glass Darklymentioning
confidence: 99%
“…Some of these prognostic markers also may be useful for disease diagnosis. [107][108][109][110][111][112][113][114] Although several series have failed to demonstrate any independent contribution of family history to the overall prognosis from prostate carcinoma, [115][116][117] it is well recognized that individuals with a family history of prostate carcinoma are at a higher risk for developing the disease than the general population. 107,118,119 The challenge for clinical research is the incorporation of appropriate risk markers into the most reliable and cost-effective models of disease outcome.…”
Section: Merging Prognosis and Diagnosis: Through A Glass Darklymentioning
confidence: 99%
“…Prostate cancer risk varies most prominently with age, ethnicity, family history, and diet [1]. A strong family history indicative of a highly penetrant prostate cancer gene is believed to account for only 5-10% of cases, but a larger percentage of prostate cancers may be due to common polymorphisms in genes giving rise to a low penetrance risk of disease [2][3][4]. The effect of polymorphisms in metabolic or DNA repair pathways on disease risk may be dependent upon the exposures that are part of these pathways [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…For example, cellular changes may be more predictive when found in subjects with a family history of disease. Furthermore, for individuals with a significant genetic polymorphism, the measurement of relevant mutagens in ductal fluid may be a powerful predictor of breast cancer risk [Coughlin and Piper, 1999]. The limits of animal models have been the determination of mutagens that are important to species-specific metabolic pathways and less relevant to human disease.…”
Section: Discussionmentioning
confidence: 99%
“…In such individuals, limited exposures may have exaggerated effects on the risk for breast cancer. The interaction of genotype and environmental exposures may be important for a large portion of "sporadic" breast cancers [Coughlin and Piper, 1999]. Genetic polymorphisms that render individuals more sensitive to specific environmental mutagens are more common than the highly penetrant breast cancer susceptibility genes, such as BRCA1/2 .…”
Section: Gene-environment Interactionsmentioning
confidence: 99%